For most families across the country, September is notable as the first full month back at school. September marks the end of carefree summer days and a return to routine: Packing lunches. Rushing out the door. Homework before dinner. Bedtime battles.
"Male nurses are found to earn about $5,000 more than female colleagues." (Not quite) shocking news!
While treatment options for lung cancer have vastly improved over the last decade, attitudes toward the disease have actually gotten worse.
As life expectancies grow longer in Lebanon, there is an increase in the amount of people diagnosed with cancer.
Wendy Sanchez, ARNP, Florida Cancer Specialists, discusses treating patients with breakthrough cancer pain.
With minimally invasive procedures to test lung cancer tumors, there often isn't enough tissue to undergo a full biomarker test, pointing toward the strength of liquid biopsies, explained Lynette M. Sholl, MD, chief of thoracic pathology at Brigham and Women's Hospital, Dana-Farber Cancer Institute, and associate professor at Harvard Medical School.
There are concerns when a patient undergoes a cytoreductive nephrectomy after immunotherapy or targeted therapy that nurses should be aware of.
Olga Ivanov, MD, surgeon at the Florida Hospital Cancer Institute, discusses survivorship in breast cancer.
Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.
Guided imagery intervention helped evaluate perceived stress levels among registered nurses, nurse educators and patient care associates.
Laura Tang, MD, PhD, a pathologist at Memorial Sloan Kettering Cancer Center, discusses the classifications of advanced neuroendocrine tumors (NETs).
With the inception of its Precision Cancer Therapies Program, the Ochsner Cancer Institute has been able to expand availability of early phase clinical trials to patients who might otherwise have had to drive up to 5 or 6 hours to participate in one.
In light of the COVID-19 pandemic, transplant-eligible patients with cancer are undergoing careful assessment to determine whether they should proceed with the procedure or receive additional consolidation therapy to buy time, according to Naval G. Daver, MD.
The FDA expanded the approval of methotrexate to include patients with pediatric acute lymphoblastic leukemia and polyarticular juvenile idiopathic arthritis.
Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.
Dr. Puneeth Iyengar expresses the importance of nutrition and hydration for patients with stage III lung cancer.
One of the great mysteries in oncology practice is the return of breast cancer many years after its initial diagnosis and treatment. And by many years, I mean 15 or even 20 years later, at a time when a woman least expects it to return.
Recent research highlighted the need for reliable information to address the educational and psychosocial needs of patients with newly diagnosed metastatic breast cancer.
Nina Kaden-Lottick describes some common challenges in survivor care.
Myelodysplastic syndromes (MDS) are a group of hematological conditions affecting the blood stem cells in the bone marrow.
Research has demonstrated that integrating palliative care early for patients with advanced cancer improves outcomes such as quality of life, mood, patient satisfaction, prognostic understanding, health service use, and survival.
Mosunetuzumab, an off-the-shelf outpatient therapy with a fixed duration of treatment, demonstrated promising responses in patients with relapsed/refractory follicular lymphoma.
The treatment of gastrointestinal cancers is a team sport, and nurses are key players.
An increasing focus in oncology care is on survivorship and quality-of-life issues that arise once patients are living beyond treatment. For female breast cancer patients, important survivorship issues include sexual and reproductive health.
Kathy Wilkinson, RN, BSN, OCN, Manager, Cancer Research, Billings Clinic Cancer Center, discusses the need for a dedicated clinical trial nurse.
Nurses may not be aware of the reproductive risks of exposure to hazardous drugs, but the new USP Chapter requires a formal notification process.
The ongoing dialogue regarding healthcare payment reform that attempts to incentivize high-value care by linking reimbursement to quality rather than quantity has largely ignored the ultimate consumer/buyer—the patient.
Amanda Yopp, NP, Clinical Nurse Educator, Takeda Oncology, discusses educating patients before they enroll on a clinic trial.
Leigh A. Neumayer, MD, professor of surgery, University of Utah School of Medicine, co-director of the multidisciplinary team treating breast cancer at Huntsman Cancer Institute, discusses patient education following a breast cancer diagnosis.
Kyung Chu, RN, NYU Langone Perlmutter Cancer Center, discusses treating patients with different subtypes of KRAS mutation.